Every lot published · search any lot number before you order

Retatrutide Phase 2 Weight-Loss Results at 48 Weeks

The randomized Phase 2 trial enrolled 338 adults and compared several retatrutide groups with placebo. At week 48 the 12 mg group had an estimated mean weight change of −24.2%, compared with −2.1% with placebo.

Retatrutide Phase 2 Weight-Loss Results at 48 Weeks. 48-week group averages. 12 mg arm, 48 weeks, 24.2% mean loss. GLP LIFE SCIENCES · RESEARCH BRIEF 11 48-week group averages Weight loss studies 12 mg arm48 weeks24.2% mean loss
48-week group averages. Illustration for this research brief.

48-week group averages

The 48-week result was a secondary time point. The primary outcome was percentage change in body weight at 24 weeks. Put the week number next to the percentage whenever quoting it.

How to interpret the evidence

Group averages summarize a distribution of responses. Read the adverse-event results and the analysis definition alongside the weight estimate.

When comparing results, record the primary outcome, the measurement week, and whether the analysis included outcomes after treatment stopped.

Sources